Antibody‐mediated suppression of Vβ5.2/5.3+ T cells in multiple sclerosis: Results from an MRI‐monitored phase II clinical trial
暂无分享,去创建一个
F. Barkhof | C. Polman | L. Blumhardt | T. Olsson | M. Khademi | C. Edenius | J. Hillert | J. Fagius | A. Landtblom | J. Killestein | A. Svenningsson | E. Wallström | L. Årfors